Biliverdin reductase B as a new target in breast cancer.
| Publicado en: | Breast Cancer Research Vol. 27; no. 1; pp. 1 - 21 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
10/16/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188712631&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 188712631 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 10/16/2025 vid: 27 iid: 1 pid: 24147 pub: BioMed Central artinfo: ui: 188712631 10.1186/s13058-025-02147-x 188712631 ppf: 1 ppct: 20 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Biliverdin reductase B as a new target in breast cancer. aug: au: Marchenko, Natalia Nesbitt, Natasha M. Alexandrova, Evguenia Reisz, Julie A. D'Alessandro, Angelo Suh, Joonhyuk Uryasev, Stan Pennacchia, Lisa Bahou, Wadie F. affil: https://ror.org/05qghxh33 Department of Pathology, Stony Brook University, 11794, Stony Brook, NY, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|